AI주식인사이트AI Stock Insight
C

서울바이오시스

092190KOSDAQ반도체 제조업

49.0 / 100

Reference Date: 2026-04-13

Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 10.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Seoul Biosys provides comprehensive solutions ranging from UV to IR, laser diodes, and VCSELs through six global R&D centers and production infrastructure, with over 7,000 patents protecting its 200nm–1600nm wavelength optical semiconductor technology. The company leads in key markets such as automotive lighting and UV LED, where it holds the top market share, and is projected to grow at a 12% annual rate across six major industries including micro LED and VCSEL.

Number of Employees

193people

Average Salary

60.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 30.084.0Point
PBR
0.97Industry Average 2.157.0Point

Half of industry avg (excellent)

ROE
-8.97Industry Average -3.943.5Point

2.3x industry avg (excellent)

Debt Ratio
38.40Industry Average 14.970.0Point

2.6x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲24.0% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲5.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -23.7% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (46%)

Current 3,575Won52-week high 5,19052-week low 2,185
1-month return1.0Point

1m -10.06% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral정기주주총회결과2026-03-26
  • Neutral사업보고서 (2025.12)2026-03-18
  • Neutral감사보고서제출2026-03-18